Pitavastatin+Ezetimibe (active substance) - analogs
Components: Pitavastatin || Ezetimibe |
|||||||||
Pharmgroups: Lipid-lowering drugs in combinations |
|||||||||
| Prices in pharmacies: Instructions Pitavastatin+Ezetimibe | |||||||||
|
ⓘ✘Enter drugs for checking interactions through a quick button search . Symphoricarpus racemosus ✘ (incl) Aristolochia milhomens ✘ (incl) Prinos verticillatus ✘ (incl) Saxitoxinum ✘ |
|
ⓘ✘ diseases to evaluate contraindications and side effects through a quick search. | ||||||
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
Pitavastatin+Ezetimibe included in the composition |
Prices in pharmacies |
-
Similar
Prices in
pharmaciesAnalogs by action ⓘ✘Analogues of the drug according to its degree of similarity with other drugs that are not direct analogues
- 81% Pitavastatin neutral
- 77% Rosuvastatin+Ezetimibe neutral [Rosuvastatin and more 1Ezetimibe]
- 71% Fenofibrate neutral
- 70% Simvastatin+Ezetimibe neutral [Simvastatin and more 1Ezetimibe]
- 67% Atorvastatin+Ezetimib neutral [Atorvastatin and more 1Ezetimibe]
- 65% Rosuvastatin+Fenofibrate neutral [Rosuvastatin and more 1Fenofibrate]
- 64% Bempedoic acid+Ezetimibe neutral [Bempedoic acid and more 1Ezetimibe]
- 56% Fluvastatin neutral
- 51% Rosuvastatin neutral
- 50% Valsartan+Rosuvastatin neutral [Valsartan and more 1Rosuvastatin]
- 48% Alirocumab neutral
- 46% Amlodipine+Rosuvastatin neutral [Amlodipine and more 1Rosuvastatin]
- 43% Amlodipine+Perindopril+Rosuvastatin neutral [Amlodipine and more 2Perindopril, Rosuvastatin]
- 43% Bempedoic acid neutral
- 42% Amlodipine+Lisinopril+Rosuvastatin neutral [Amlodipine and more 2Lisinopril, Rosuvastatin]
- 37% Evolocumab neutral
- 35% Ezetimibe neutral
- 35% Amlodipine+Atorvastatin neutral [Amlodipine and more 1Atorvastatin]
- 33% Simvastatin neutral
- 33% Laropiprant+Nicotinic acid neutral [Nicotinic acid]
- 32% Colestyramine neutral
- 30% Atorvastatin neutral
- 30% Lovastatin neutral
- 27% Acetylsalicylic acid+Rosuvastatin neutral [Acetylsalicylic acid and more 1Rosuvastatin]
- 26% Atorvastatin+Acetylsalicylic acid neutral [Atorvastatin and more 1Acetylsalicylic acid]
- 22% Amlodipine+Atorvastatin+Perindopril neutral [Amlodipine and more 2Atorvastatin, Perindopril]
- 22% Inclisiran neutral
- 21% Betaine neutral
- 20% Pravastatin neutral
- 20% Betaine+Pepsin neutral [Betaine and more 1Pepsin]
- 19% Indapamide+Perindopril+Rosuvastatin neutral [Indapamide and more 2Perindopril, Rosuvastatin]
- 17% Metformin+[Sibutramine+Cellulose microcrystallic] neutral [Metformin and more 1Sibutramine]
- 17% Tribuli terrestris herbae extract neutral
- 16% Metformin+Sibutramine neutral [Metformin and more 1Sibutramine]
- 16% Bezafibrate neutral
- 16% Omega-3-triglycerides [EPA/DHA=1.2/1 - 90%] neutral
- 15% Sibutramine+[Cellulose microcristallic] neutral [Sibutramine]
- 15% Dioscoreae nipponicae rhizomatum cum radicibus extract neutral
- 15% Cucurbitae semenis oleum neutral
- 15% Probucol neutral
- 14% Magnesium orotate neutral
- 13% Amlodipine+Lisinopril neutral [Amlodipine and more 1Lisinopril]
- 13% Becaplermin neutral
- 13% Vaccine influenza virus inactivated neutral
- 13% Persicarii hydropiperis herbae extract neutral
- 13% Ergometrine neutral
- 12% Aminocaproic acid neutral
- 12% Thioctic acid neutral
- 12% Tunica semenum Plantaginis ovatae neutral
- 12% Fructose neutral
Learn more about the selection of analogues
▶
- The drug has «Pitavastatin+Ezetimibe» 51 analog by action, the most similar - Pitavastatin .
- Medical online service has selected the best substitutes for Pitavastatin+Ezetimibe based on its instructions, components, pharmaceutical groups and practical application.
- The table shows the prices of analogues Pitavastatin+Ezetimibe to choose the cheapest pills.
- If you have introduced other drugs for registration, substitutes are selected taking into account the assessment of interactions and safety.
- Sometimes, due to the presence of dangerous interactions, it is necessary to use drugs that are similar in effect, sometimes even from different pharmacological groups.